Mostafa M. Bahaa

A randomized placebo-controlled, double-blind study to investigate the effect of a high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients, new insights on serum STAT-3 and hepassocin.

Sumaiah J. Alarfaj, Mostafa M. Bahaa, H A Yassin et al. · PubMed · 2023 · 27 citations

Repurposing metformin as adjuvant therapy in patients with ulcerative colitis treated with mesalamine: A randomized controlled double-blinded study

Sahar M El-Haggar, Sahar K Hegazy, M Maher et al. · International Immunopharmacology · 2024 · 21 citations

Inflammation, Anti-inflammatory, Gastrointestinal Pharmacology +7

Pentoxifylline, a nonselective phosphodiesterase inhibitor, in adjunctive therapy in patients with irritable bowel syndrome treated with mebeverine

Sahar M. El‐Haggar, Sahar K. Hegazy, Sherief Abd‐Elsalam et al. · Biomedicine & Pharmacotherapy · 2021 · 18 citations · Full text

Pentoxifylline in patients with ulcerative colitis treated with mesalamine by modulation of IL-6/STAT3, ZO-1, and S1P pathways: a randomized controlled double-blinded study

Mostafa M. Bahaa, Sahar K. Hegazy, M Maher et al. · Inflammopharmacology · 2024 · 17 citations

Inflammation, Anti-inflammatory, Autoimmune Disease +8

Cyclin‐dependent kinase 5 (<scp>CDK5</scp>) inhibitors in Parkinson disease

Mohammed Alrouji, Haydar M. Al‐kuraishy, Ali I. Al‐Gareeb et al. · Journal of Cellular and Molecular Medicine · 2024 · 13 citations · Full text